
Developing the next generation of cancer vaccines

Irazu Oncology
-
Marco Chacon, PhD
Founder & President
Successful entrepreneur and former CEO and Chairman of Paragon Biosciences, Inc., a CDMO specialized in product development and GMP manufacturing of vaccines and viral vectors for gene therapy.
-
Marcio Chedid, PhD
Chief Scientific Officer
Experience in oncology small and large molecule drug discovery and clinical development. Former Executive Director of Biotechnology Discovery at Eli Lilly Co.
-
Kevin Chen, PhD
Principal Scientist
Background in microbiology and immunology. Expertise in disease modeling, antibody discovery and engineering and live vector delivery systems for vaccines and antibodies.
-
Brad Cawthern
Director of Operations
Background in GMP microbiology and IT. Expert in biopharma quality systems and bench -> plant -> patient project scalability with focus on safety and quality.